NexImmune Inc. (NEXI)
OTC: NEXI
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Apr 04, 2025, 11:37 AM
NexImmune Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.33M | -3.08M | -5.36M | -9.85M | -7.57M | -9.57M | -16.89M | -14.73M | -15.86M | -15.02M | -15.53M | -14.65M | -12.18M | -8.55M |
Depreciation & Amortization | 114.91K | 114.91K | 228.51K | 265.54K | 267.16K | 263.77K | 264.09K | 260.87K | 242.87K | 226.96K | 243.24K | 233.17K | 219.54K | 174.33K |
Stock-Based Compensation | 280.54K | 348.3M | 614.15K | 1.11M | 991.13K | 842.45K | 1.48M | 1.44M | 1.31M | 1.65M | 1.67M | 1.63M | 1.48M | 1.2M |
Other Working Capital | -249.93K | 359.25K | -2.7M | 880.24K | 214.02K | -2.23M | 2.85M | 977.36K | 3.12M | -4.4M | 4.73M | 2.69M | -3.95M | -1.81M |
Other Non-Cash Items | -400.67K | -347.55M | 106.43K | 167.16K | 133.07K | 130.74K | 54.9K | 209.49K | 136K | 120.29K | -2.21M | -835.28K | 1.00 | 903.92K |
Deferred Income Tax | n/a | n/a | 679.97K | -3.69K | n/a | n/a | n/a | n/a | n/a | n/a | 2.17M | n/a | n/a | -2.43M |
Change in Working Capital | 259.62K | -205.45K | -2.1M | 1.04M | 145.96K | -3.96M | 3.97M | 955.07K | 2.45M | -3.45M | 2.21M | 4.04M | -3.13M | -2.46M |
Operating Cash Flow | -2.07M | -2.42M | -5.83M | -7.28M | -6.03M | -12.28M | -11.12M | -11.87M | -11.72M | -16.48M | -11.44M | -9.58M | -13.61M | -11.16M |
Capital Expenditures | n/a | n/a | -48.67M | -981 | -5.02K | -42.72K | -223.96K | -562.73K | -124.06K | -344.36K | -515.71K | -200.12K | -1.05M | -581.23K |
Cash Acquisitions | n/a | n/a | -4.23K | 4.23K | n/a | n/a | n/a | n/a | n/a | -1.62M | -71.05M | n/a | n/a | 464.00 |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.47M | -16.04M | -34.48M | -17M | -38.98M | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.5M | 33.5M | 27M | 39M | n/a | n/a | n/a |
Other Investing Acitivies | 43.58K | 522.55K | 4.23M | n/a | n/a | n/a | 80.8K | n/a | n/a | 1.62M | 71.05M | n/a | -38.98M | 464.00 |
Investing Cash Flow | 43.58K | 522.55K | -44.45M | 3.25K | -5.02K | -42.72K | -143.16K | 11.94M | 27.9M | 10.62M | 4M | -17.2M | -40.03M | -580.76K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.74K | -5.31K | 9.03M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 33.26K | 504.37K | 214.8K | 149.77K | 277.95K |
Financial Cash Flow | n/a | 3.14M | n/a | n/a | n/a | n/a | n/a | 5.15M | n/a | 33.26K | 504.37K | 213.07K | -637.97K | 124.81M |
Net Cash Flow | -2.03M | 1.25M | -5.83M | -7.28M | -6.03M | -12.33M | -11.27M | 5.22M | 16.18M | -5.82M | -6.93M | -26.56M | -54.29M | 113.07M |
Free Cash Flow | -2.07M | -2.42M | -54.5M | -7.29M | -6.03M | -12.33M | -11.35M | -12.43M | -11.85M | -16.82M | -11.95M | -9.78M | -14.67M | -11.74M |